Abstract
The putative oestrogen receptor negative human breast cancer cell line MDA231, when grown as tumours in mice continually receiving 17β-oestradiol, showed substantially increased growth rate when compared to control animals. Further, we observed that 17β-oestradiol treatment could both increase the growth rate of established MDA231 tumours as well as decreasing the time taken for initiating tumour growth. We have also demonstrated that this increase in growth rate is accompanied by a four-fold increase in nitric oxide synthase activity, which was predominantly the inducible form. Inducible-nitric oxide synthase expression in these tumours was confirmed by immunohistochemical analysis and appeared localized primarily in areas between viable and necrotic regions of the tumour (an area that is presumably hypoxic). Prophylactic treatment with the nitric oxide synthase inhibitor nitro-L-arginine methyl ester resulted in significant reduction in this apparent 17β-oestradiol-mediated growth promoting effect. Tumours derived from mice receiving 17β-oestradiol-treatment were characterized by a significantly lower fraction of perfused blood vessels and an indication of an increased hypoxic fraction. Consistent with these observations, 17β-oestradiol-treated tumours were less radio-responsive compared to control tumours when treated with a single radiation dose of 15 Gy. Our data suggests that long-term treatment with oestrogen could significantly alter the tumour oxygenation status during breast tumour progression, thus affecting response to radiotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrade SP, Hart IR, Piper PJ (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 107: 1092–1097
Bailey MJ, Gazet JC, Smith IE, Steel GG (1980) Chemotherapy of human breast carcinoma xenografts. Br J Cancer 42: 530–536
Bussink J, Kaanders JH, Rijken PF, Martindale CA, van der Kogel AJ (1998) Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br J Cancer 77: 57–64
Carson DA, Ribeiro JM (1993) Apoptosis and disease. Lancet 341: 1251–1254
Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727–730
Dechering K, Boersma C, Mosselman S (2000) Estrogen receptors alpha and beta: Two receptors of a kind? Curr Med Chem 7: 561–576
Dickson RB, Lippman ME (1987) Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev 8: 29–43
Fodstad Ø, Hansen CT, Cannon GB, Statham CN, Lichtenstein GR, Boyd MR (1984) Lack of correlation between natural killer cell activity and tumor growth control in nude mice with different immune defects. Cancer Res 44: 4403–4408
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27–30
Friedl A, Gottardis MM, Pink J, Buchler DA, Jordan VC (1989) Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice. Cancer Res 49: 4758–4764
Friedl A, Jordan VC (1994) Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss. Eur J Cancer 30A: 1559–1564
Fuqua SAW, Schiff R, Parra I, Friedrichs WE, Su J, Mckee DD, Slentz-Kesler K, Moore LB, Wilson TM, Moore JT (1999) Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer. Cancer Res 59: 5425–5428
Gleiber WE, Schiffman E (1984) Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines. Cancer Res 44: 3398–3402
Heberman RB, Holden HT (1979) Natural killer cells as antitumor effector cells. J Natl Cancer Inst 62: 441–445
Howard-Flanders P (1957) Effect of nitric oxide on the radiosensitivity of bacteria. Nature 180: 1191–1192
Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S (1995) Roles of nitric oxide in tumour growth. Proc Natl Acad Sci USA 92: 4392–4396
Kim YM, Bergonia H, Lancaster Jr JR (1995) Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett 374: 228–232
Kopper L, Steel GG (1975) The therapeutic response of three human tumour lines maintained in immuno-suppressed mice. Cancer Res 35: 2704–2713
Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR (1984) Metastatic behaviour of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522–3529
Leygue E, Dotzlaw H, Watson PH, Murphy LC (1998) Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res 58: 3197–3201
Leygue E, Dotzlaw H, Watson PH, Murphy LC (1999) Expression of estrogen receptor β1, β2, and β5 messenger RNAs in human breast tissue. Cancer Res 59: 1175–1179
Lopez-Farre A, Rodrguez-Feo JA, Sanchez de Miguel L, Rico L, Casado S (1998) Role of nitric oxide in the control of apoptosis in the microvasculature. Int J Biochem Cell Biol 30: 1095–1106
McGuire WL, Carbone PP, Vollmer EP (1975) Estrogen receptors in human breast cancer. New York: Raven Press
Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Veresio L (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683–1693
Mikulski SM (1994) Pathogenesis of cancer in view of mutually opposing apoptotic and anti-apoptotic growth signals. Intl J Oncol 4: 1257–1263
Minchenko A, Bauer T, Salceda S, Caro J (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374–379
Mitchell JB, Wink DA, DeGraff W, Gamson J, Keefer LK, Krishna MC (1993) Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res 53: 5845–5848
Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051–3064
Nenci I, Marchetti E, Querzoli P (1988) Commentary on human mammary preneoplasia. The estrogen receptor-promotion hypothesis. J Steriod Biochem 30: 105–106
O'Rourke JF, Dachs GU, Gleadle JM, Maxwell PH, Pugh CW, Stratford IJ, Wood SM, Ratcliffe PJ (1997) Hypoxia response elements. Oncol Res 9: 327–332
Pujol P, Jey J, Nirde P, Roger P, Gastaldi M, Laffargue F, Rochefort H, Maudelonde T (1998) Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 58: 5367–5373
Seaman WE, Blackman MA, Gindhart TD, Roubinian JR, Loeb JM, Talal N (1978) Beta-estradiol reduces natural killer cells in mice. J Immunol 121: 2193–2198
Shafie SM, Grantham FH (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67: 51–56
Shakhar G, Ben-Eliyahu S (1998) In vivo beta-adrenergic stimulation suppresses natural killer activity and compromise resistance to tumor metastasis in rats. J Immunol 160: 3251–3258
Sutherland RM, Rasey JS, Hill RP (1988) Tumor biology. Am J Clin Oncol 11: 253–274
Talmadge JE, Meyers KM, Prieur DJ, Starkey JR (1980) Role of NK cells in tumour growth and metastasis in beige mice. Nature (Lond) 284: 622–624
Thomsen LL, Lawton FG, Knowles RG, Beesley JF, Riveros-Moreno V, Moncada S (1994) Nitric oxide synthase activity in human gynaecological cancer. Cancer Res 54: 1352–1354
Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41–44
Thomsen LL, Scott JMJ, Topley P, Knowles RG, Keerie A, Frend AJ (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor. Cancer Res 57: 3300–3304
Topper J, Freedman C (1980) Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60: 1049–1060
Van der Burg B, Isbrueker L, Van Selm-Miltenburg AJP, De Laat SW, Van Zoelen EJJ (1990) Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. Cancer Res 50: 7770–7774
Vladusic EA, Hornby EA, Guerra-Vladusic FK, Lakins J, Lapu R (1998) Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res 58: 210–214
Vladusic EA, Hornby EA, Guerra-Vladusic FK, Lakins J, Lapu R (2000) Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol Reports 7: 157–167
Weigel RJ, deConnick EC (1993) Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 53: 3472–3474
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S (1994) Induction of calcium-dependent nitric oxide by sex hormones. Proc Natl Acad Sci USA 91: 5212–5216
Wood PJ, Sansom JM, Butler SA, Stratford IJ, Cole SM, Szabo C, Thiemermann C, Adams GE (1994a) Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, Ng-nitro-L-arginine. Cancer Res 54: 6458–6463
Wood PJ, Sansom J, Stratford IJ, Adams GE, Szabo C, Thiemermann C, Vane JR (1994b) Modification of energy metabolism in transplantable and spontaneous tumors by the nitric oxide synthase inhibitor nitro-L-arginine. Int J Radiat Oncol Biol Phys 29: 443–447
Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen RJ, Lippman ME, Rosen N (1989) Analysis of insulin-like growth factor gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3: 509–517
Acknowledgements
We wish to thank Mr Terry Hacker of the MRC Radiation and Genome Stability Unit, Harwell, Didcot, for carrying out NOS immunohistology on tumour sections. This study was jointly supported by grants from the Association for International Cancer Research (AICR) and the Medical Research Council (MRC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chinje, E., Williams, K., Telfer, B. et al. 17β-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response. Br J Cancer 86, 136–142 (2002). https://doi.org/10.1038/sj.bjc.6600032
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600032
Keywords
This article is cited by
-
Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
Breast Cancer Research (2015)
-
Targeting hypoxia in cancer therapy
Nature Reviews Cancer (2011)